{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T22:30:38Z","timestamp":1787610638698,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.pbb.2015.05.018","type":"journal-article","created":{"date-parts":[[2015,6,5]],"date-time":"2015-06-05T00:56:27Z","timestamp":1433465787000},"page":"154-168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Antidepressant\/anxiolytic potential and adverse effect liabilities of melanin-concentrating hormone receptor 1 antagonists in animal models"],"prefix":"10.1016","volume":"135","author":[{"given":"Shigeyuki","family":"Chaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiharu","family":"Shimazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Nishiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeo","family":"Funakoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michihiko","family":"Iijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akie","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Kanuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Sekiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2015.05.018_bb0005","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1176\/appi.ajp.2008.07071199","article-title":"A 6-week randomized, placebo-controlled trial of CP-316,311 (a selective CRH1 antagonist) in the treatment of major depression","volume":"165","author":"Binneman","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pbb.2015.05.018_bb0010","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/cne.903190204","article-title":"The melanin-concentrating hormone system of the rat brain: an immuno- and hybridization histochemical characterization","volume":"319","author":"Bittencourt","year":"1992","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.pbb.2015.05.018_bb0015","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/nm0902-1039b","article-title":"Antidepressant, anxiolytic and anorectic effects of a melanin-concentrating hormone-1 receptor antagonist","volume":"8","author":"Borowsky","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.pbb.2015.05.018_bb0020","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00213-002-1155-6","article-title":"Do animal models of anxiety predict anxiolytic-like effects of antidepressants?","volume":"163","author":"Borsini","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2015.05.018_bb0030","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1124\/jpet.102.044826","article-title":"Anxiolytic-like and antidepressant-like activities of MCL0129 (1-[(S)-2-(4-fluorophenyl)-2-(4-isopropylpiperadin-1-yl)ethyl]-4-[4-(2-methoxynaphthalen-1-yl)butyl]piperazine), a novel and potent nonpeptide antagonist of the melanocortin-4 receptor","volume":"304","author":"Chaki","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2015.05.018_bb0035","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ejphar.2003.11.032","article-title":"Anxiolytic- and antidepressant-like profile of a new CRF1 receptor antagonist, R278995\/CRA0450","volume":"485","author":"Chaki","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2015.05.018_bb0025","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1124\/jpet.104.081711","article-title":"Anxiolytic- and antidepressant-like profile of ATC0065 and ATC0175: nonpeptidic and orally active melanin-concentrating hormone receptor 1 antagonists","volume":"313","author":"Chaki","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2015.05.018_bb0040","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00213-005-0093-5","article-title":"Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment","volume":"182","author":"Cryan","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2015.05.018_bb0045","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1124\/jpet.106.109678","volume":"321","author":"David","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2015.05.018_bb0050","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF03001163","article-title":"Conditioned and unconditional components of post-shock freezing","volume":"15","author":"Fanselow","year":"1980","journal-title":"Pavlov. J. Biol. Sci."},{"key":"10.1016\/j.pbb.2015.05.018_bb0055","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0006-8993(98)01160-3","article-title":"Dizocilpine does not prevent the development of tolerance to the anxiolytic effects of diazepam in rats","volume":"815","author":"Fernandes","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.pbb.2015.05.018_bb0060","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1124\/jpet.108.143362","article-title":"Preclinical evaluation of melanin-concentrating hormone receptor 1 antagonism for the treatment of obesity and depression","volume":"329","author":"Gehlert","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2015.05.018_bb0065","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1523\/JNEUROSCI.1714-04.2005","article-title":"The hypothalamic neuropeptide melanin-concentrating hormone acts in the nucleus accumbens to modulate feeding behavior and forced-swim performance","volume":"25","author":"Georgescu","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pbb.2015.05.018_bb0070","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/nrd3702","article-title":"Neuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning?","volume":"11","author":"Griebel","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.pbb.2015.05.018_bb0075","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.4088\/JCP.12m07804","article-title":"The vasopressin V(1b) receptor antagonist SSR149415 in the treatment of major depressive and generalized anxiety disorders: results from 4 randomized, double-blind, placebo-controlled studies","volume":"73","author":"Griebel","year":"2012","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.pbb.2015.05.018_bb0080","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1046\/j.1460-9568.2000.00008.x","article-title":"The distribution of the mRNA and protein products of the melanin-concentrating hormone (MCH) receptor gene, slc-1, in the central nervous system of the rat","volume":"12","author":"Hervieu","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pbb.2015.05.018_bb0085","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.tips.2003.09.011","article-title":"Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders","volume":"24","author":"Holmes","year":"2003","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.pbb.2015.05.018_bb0090","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1111\/bph.12699","article-title":"Antidepressant and anxiolytic profiles of newly synthesized arginine vasopressin receptor 1B antagonists: TASP0233278 and TASP0390325","volume":"171","author":"Iijima","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pbb.2015.05.018_bb0095","first-page":"1024","article-title":"Rat melanin-concentrating hormone stimulates adrenocorticotropin secretion: evidence for a site of action in brain regions protected by the blood\u2013brain barrier","volume":"130","author":"Jezova","year":"1992","journal-title":"Endocrinology"},{"key":"10.1016\/j.pbb.2015.05.018_bb0100","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.biopsych.2005.07.013","article-title":"Lack of efficacy of the substance p (neurokinin1 receptor) antagonist aprepitant in the treatment of major depressive disorder","volume":"59","author":"Keller","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2015.05.018_bb0105","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1046\/j.1365-2826.2003.00997.x","article-title":"Effect of direct injection of melanin-concentrating hormone into the paraventricular nucleus: further evidence for a stimulatory role in the adrenal axis via SLC-1","volume":"15","author":"Kennedy","year":"2003","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.pbb.2015.05.018_bb0110","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/S0196-9781(97)00036-3","article-title":"Melanin-concentrating hormone (MCH) involvement in pentylenetetrazole (PTZ)-induced seizure in rat and guinea pig","volume":"18","author":"Knigge","year":"1997","journal-title":"Peptides"},{"key":"10.1016\/j.pbb.2015.05.018_bb0115","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.bbr.2010.10.035","article-title":"Depressive-like profile induced by MCH microinjections into the dorsal raphe nucleus evaluated in the forced swim test","volume":"218","author":"Lagos","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pbb.2015.05.018_bb0120","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.neuron.2007.07.041","article-title":"Serotonin(4) (5-HT(4)) receptor agonists are putative antidepressants with a rapid onset of action","volume":"55","author":"Lucas","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.pbb.2015.05.018_bb0125","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1017\/S1461145708008894","article-title":"The melanin-concentrating hormone1 receptor antagonists, SNAP-7941 and GW3430, enhance social recognition and dialysate levels of acetylcholine in the frontal cortex of rats","volume":"11","author":"Millan","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pbb.2015.05.018_bb0130","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/S0196-9781(99)00164-3","article-title":"Melanin-concentrating hormone (MCH) modifies memory retention in rats","volume":"20","author":"Monzon","year":"1999","journal-title":"Peptides"},{"key":"10.1016\/j.pbb.2015.05.018_bb0135","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0022-3565(24)38220-5","article-title":"Receptor binding, behavioral, and electrophysiological profiles of nonpeptide corticotropin-releasing factor subtype 1 receptor antagonists CRA1000 and CRA1001","volume":"289","author":"Okuyama","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2015.05.018_bb0145","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.neulet.2010.08.018","article-title":"Mice lacking melanin concentrating hormone 1 receptor are resistant to seizures","volume":"484","author":"Parks","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pbb.2015.05.018_bb0140","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1986"},{"key":"10.1016\/j.pbb.2015.05.018_bb0155","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/sj.npp.1300805","article-title":"Genetic inactivation of melanin-concentrating hormone receptor subtype 1 (MCHR1) in mice exerts anxiolytic-like behavioral effects","volume":"31","author":"Roy","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2015.05.018_bb0150","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.biopsych.2006.03.076","article-title":"A study of the involvement of melanin-concentrating hormone receptor 1 (MCHR1) in murine models of depression","volume":"61","author":"Roy","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2015.05.018_bb0160","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/cne.1191","article-title":"Expression of the melanin-concentrating hormone (MCH) receptor mRNA in the rat brain","volume":"435","author":"Saito","year":"2001","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.pbb.2015.05.018_bb0165","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s00213-007-0699-x","article-title":"Effects of milnacipran and fluvoxamine on hyperemotional behaviors and the loss of tryptophan hydroxylase-positive cells in olfactory bulbectomized rats","volume":"191","author":"Saitoh","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2015.05.018_bb0170","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejphar.2006.06.032","article-title":"The pituitary mediates the anxiolytic-like effects of the vasopressin V1B receptor antagonist, SSR149415, in a social interaction test in rats","volume":"543","author":"Shimazaki","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2015.05.018_bb0175","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00213-006-0630-x","article-title":"Evaluation of reward processes in an animal model of depression","volume":"190","author":"Slattery","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2015.05.018_bb0190","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1523\/JNEUROSCI.4079-04.2005","article-title":"Mesolimbic dopamine super-sensitivity in melanin-concentrating hormone-1 receptor-deficient mice","volume":"25","author":"Smith","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pbb.2015.05.018_bb0180","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/sj.npp.1300913","article-title":"Melanin-concentrating hormone-1 receptor modulates neuroendocrine, behavioral, and corticolimbic neurochemical stress responses in mice","volume":"31","author":"Smith","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2015.05.018_bb0185","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.bbr.2008.08.026","article-title":"The effects of stressful stimuli and hypothalamic-pituitary-adrenal axis activation are reversed by the melanin-concentrating hormone 1 receptor antagonist SNAP 94847 in rodents","volume":"197","author":"Smith","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pbb.2015.05.018_bb0195","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0014-2999(85)90467-4","article-title":"Subtypes of the 5-HT receptor mediating the behavioural responses to 5-methoxy-N,N-dimethyltryptamine in the rat","volume":"117","author":"Tricklebank","year":"1985","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2015.05.018_bb0200","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.peptides.2003.09.006","article-title":"Increased susceptibility to LTP generation and changes in NMDA-NR1 and -NR2B subunits mRNA expression in rat hippocampus after MCH administration","volume":"24","author":"Varas","year":"2003","journal-title":"Peptides"},{"key":"10.1016\/j.pbb.2015.05.018_bb0205","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00213-006-0390-7","article-title":"An mGluR2\/3 antagonist, MGS0039, exerts antidepressant and anxiolytic effects in behavioral models in rats","volume":"186","author":"Yoshimizu","year":"2006","journal-title":"Psychopharmacology (Berl)"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009130571530006X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009130571530006X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T10:24:19Z","timestamp":1748427859000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009130571530006X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":41,"alternative-id":["S009130571530006X"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2015.05.018","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antidepressant\/anxiolytic potential and adverse effect liabilities of melanin-concentrating hormone receptor 1 antagonists in animal models","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2015.05.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}